Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 175

1.

Practical issues with amisulpride in the management of patients with schizophrenia.

Pani L, Villagrán JM, Kontaxakis VP, Alptekin K.

Clin Drug Investig. 2008;28(8):465-77. Review.

PMID:
18598092
3.

Olanzapine versus other atypical antipsychotics for schizophrenia.

Komossa K, Rummel-Kluge C, Hunger H, Schmid F, Schwarz S, Duggan L, Kissling W, Leucht S.

Cochrane Database Syst Rev. 2010 Mar 17;(3):CD006654. doi: 10.1002/14651858.CD006654.pub2. Review.

4.

Amisulpride versus olanzapine in the treatment of schizophrenia in Indian patients: randomized controlled trial.

Bhowmick S, Hazra A, Ghosh M.

Aust N Z J Psychiatry. 2010 Mar;44(3):237-42. doi: 10.3109/00048670903487134.

PMID:
20050717
5.

Risperidone versus other atypical antipsychotics for schizophrenia.

Komossa K, Rummel-Kluge C, Schwarz S, Schmid F, Hunger H, Kissling W, Leucht S.

Cochrane Database Syst Rev. 2011 Jan 19;(1):CD006626. doi: 10.1002/14651858.CD006626.pub2. Review.

6.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
7.

Amisulpride: a review of its use in the management of schizophrenia.

McKeage K, Plosker GL.

CNS Drugs. 2004;18(13):933-56. Review.

PMID:
15521794
8.
9.

Amisulpride: a review of its use in the management of schizophrenia.

Curran MP, Perry CM.

Drugs. 2001;61(14):2123-50. Review.

PMID:
11735643
10.

Spotlight on amisulpride in schizophrenia.

Curran MP, Perry CM.

CNS Drugs. 2002;16(3):207-11. Review.

PMID:
11888341
11.

Amisulpride for schizophrenia.

Mota NE, Lima MS, Soares BG.

Cochrane Database Syst Rev. 2002;(2):CD001357. Review.

PMID:
12076408
12.

Quetiapine : A Review of its Use in Schizophrenia.

Gunasekara NS, Spencer CM.

CNS Drugs. 1998 Apr;9(4):325-40. doi: 10.2165/00023210-199809040-00007.

PMID:
27521016
13.

Amisulpride augmentation in patients with schizophrenia partially responsive or unresponsive to clozapine. A randomized, double-blind, placebo-controlled trial.

Assion HJ, Reinbold H, Lemanski S, Basilowski M, Juckel G.

Pharmacopsychiatry. 2008 Jan;41(1):24-8. doi: 10.1055/s-2007-993209.

PMID:
18203048
14.

An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.

Krzystanek M, Krupka-Matuszczyk I.

Hum Psychopharmacol. 2011 Jan;26(1):81-5. doi: 10.1002/hup.1173. Epub 2011 Feb 9. Review.

PMID:
23055416
15.

Augmentation treatment with amisulpride in schizophrenic patients partially responsive to olanzapine.

Molina JD, Toledo-Romero F, López-Rodríguez E, Amorin-Díaz M, Lerma-Carrillo I, López-Muñoz F.

Pharmacopsychiatry. 2011 Jun;44(4):142-7. doi: 10.1055/s-0031-1279728. Epub 2011 Jun 27.

PMID:
21710404
16.

Ziprasidone versus other atypical antipsychotics for schizophrenia.

Komossa K, Rummel-Kluge C, Hunger H, Schwarz S, Bhoopathi PS, Kissling W, Leucht S.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD006627. doi: 10.1002/14651858.CD006627.pub2. Review.

17.

Amisulpride, an unusual "atypical" antipsychotic: a meta-analysis of randomized controlled trials.

Leucht S, Pitschel-Walz G, Engel RR, Kissling W.

Am J Psychiatry. 2002 Feb;159(2):180-90.

PMID:
11823257
18.

Amisulpride: progress and outcomes.

Lecrubier Y.

Curr Med Res Opin. 2002;18 Suppl 3:s18-22. Review.

PMID:
12418608
19.
20.

Amisulpride versus other atypical antipsychotics for schizophrenia.

Komossa K, Rummel-Kluge C, Hunger H, Schmid F, Schwarz S, Silveira da Mota Neto JI, Kissling W, Leucht S.

Cochrane Database Syst Rev. 2010 Jan 20;(1):CD006624. doi: 10.1002/14651858.CD006624.pub2. Review.

Supplemental Content

Support Center